[1]
|
周京敏, 王华, 黎励文. 射血分数保留的心力衰竭诊断与治疗中国专家共识2023 [J]. 中国循环杂志, 2023, 38(4): 375-393.
|
[2]
|
张健, 张宇辉, 周蕾. 国家心力衰竭指南2023[J]. 中国循环杂志, 2023, 38(12): 1207-1238.
|
[3]
|
张志扬, 蔡蔚萍, 吴志辉, 等. 不同射血分数心力衰竭患者临床特征和预后分析[J]. 医学理论与实践, 2023, 36(18): 3065-3068. https://doi.org/10.19381/j.issn.1001-7585.2023.18.002
|
[4]
|
Metra, M. and Lucioli, P. (2020) Corrigendum to ‘Prevalence of Heart Failure and Left Ventricular Dysfunction in China: The China Hypertension Survey, 2012-2015’ [Eur J Heart Fail 2019;21:1329-1337]. European Journal of Heart Failure, 22, 759. https://doi.org/10.1002/ejhf.1808
|
[5]
|
王华, 李莹莹, 柴坷, 等. 中国住院心力衰竭患者流行病学及治疗现状[J]. 中华心血管病杂志, 2019, 47(11): 865-874. https://rs.yiigle.com/CN2021/1169262.htm
|
[6]
|
中华医学会心血管病学分会心力衰竭学组, 中国医师协会心力衰竭专业委员会, 中华心血管病杂志编辑委员会.中国心力衰竭诊断和治疗指南2018[J]. 中华心血管病杂志, 2018, 46(10): 760-789. https://rs.yiigle.com/cn112148201810/1071728.htm?from=groupmessage&isappinstalled=0
|
[7]
|
陈希瑶, 张富洋. 心力衰竭易损期的定义与药物治疗[J]. 心脏杂志, 2022, 34(3): 348-351. http://www.heartj.cn/cn/article/doi/10.12125/j.chj.202103061
|
[8]
|
Dharmarajan, K., Hsieh, A.F., Lin, Z., Bueno, H., Ross, J.S., Horwitz, L.I., Barreto-Filho, J.A., Kim, N., Bernheim, S.M., Suter, L.G., Drye, E.E. and Krumholz, H.M. (2013) Diagnoses and Timing of 30-day Readmissions after Hospitalization for Heart Failure, Acute Myocardial Infarction, or Pneumonia. JAMA, 309, 355-363. https://doi.org/10.1001/jama.2012.216476
|
[9]
|
Greene, S.J., Fonarow, G.C., Vaduganathan, M., Khan, S.S., Butler, J. and Gheorghiade, M. (2015) The Vulnerable Phase after Hospitalization for Heart Failure. Nature Reviews Cardiology, 12, 220-229. https://doi.org/10.1038/nrcardio.2015.14
|
[10]
|
Zile, M.R., Bennett, T.D., St John Sutton, M., Cho, Y.K., Adamson, P.B., Aaron, M.F., Aranda Jr., J.M, Abraham, W.T., Smart, F.W., Stevenson, L.W., Kueffer, F.J. and Bourge, R.C. (2008) Transition from Chronic Compensated to Acute Decompensated Heart Failure: Pathophysiological Insights Obtained from Continuous Monitoring of Intracardiac Pressures. Circulation, 118, 1433-1441. https://doi.org/10.1161/CIRCULATIONAHA.108.783910
|
[11]
|
Heymans, S., Hirsch, E., Anker, S.D., Aukrust, P., Balligand, J.L., Cohen-Tervaert, J.W., Drexler, H., Filippatos, G., Felix, S.B., Gullestad, L., Hilfiker-Kleiner, D., Janssens, S., Latini, R., Neubauer, G., Paulus, W.J., Pieske, B., Ponikowski, P., Schroen, B., Schultheiss, H.P., Tschöpe, C., Van Bilsen, M., Zannad, F., McMurray, J. and Shah, A.M. (2009) Inflammation as a Therapeutic Target in Heart Failure? A Scientific Statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology. European Journal of Heart Failure, 11, 119-129. https://doi.org/10.1093/eurjhf/hfn043
|
[12]
|
Kaur, G., Baghdasaryan, P., Natarajan, B., Sethi, P., Mukherjee, A., Varadarajan, P. and Pai, R.G. (2021) Pathophysiology, Diagnosis, and Management of Coronary No-Reflow Phenomenon. International Journal of Angiology, 30, 15-21. https://doi.org/10.1055/s-0041-1725979
|
[13]
|
刘丹勇, 夏正远, 韩荣辉, 等. 心肌缺血再灌注损伤机制研究的回顾与展望[J]. 中国动脉硬化杂志, 2020, 28(12): 1013-1019.
|
[14]
|
Bueno, H., Ross, J.S., Wang, Y., Chen, J., Vidán, M.T., Normand, S.L., Curtis, J.P., Drye, E.E., Lichtman, J.H., Keenan, P.S., Kosiborod, M. and Krumholz, H.M. (2010) Trends in Length of Stay and Short-Term Outcomes among Medicare Patients Hospitalized for Heart Failure, 1993-2006. JAMA, 303, 2141-2147. https://doi.org/10.1001/jama.2010.748
|
[15]
|
Wu, F., Wang, Q., Qiao, Y., Yu, Q. and Wang, F. (2022) A New Marker of Short-Term Mortality and Poor Outcome in Patients with Acute Ischemic Stroke: Mean Platelet Volume-to-Lymphocyte Ratio. Medicine, 101, e30911. https://doi.org/10.1097/MD.0000000000030911
|
[16]
|
Becatti, M., Fiorillo, C., Gori, A.M., Marcucci, R., Paniccia, R., Giusti, B., Violi, F., Pignatelli, P., Gensini, G.F. and Abbate, R. (2013) Platelet and Leukocyte ROS Production and Lipoperoxidation Are Associated with High Platelet Reactivity in Non-ST Elevation Myocardial Infarction (NSTEMI) Patients on Dual Antiplatelet Treatment. Atherosclerosis, 231, 392-400. https://doi.org/10.1016/j.atherosclerosis.2013.09.030
|
[17]
|
Bath, P.M. and Butterworth, R.J. (1996) Platelet Size: Measurement, Physiology and Vascular Disease. Blood Coagulation & Fibrinolysis, 7, 157-161. https://doi.org/10.1097/00001721-199603000-00011
|
[18]
|
Ot, S., Zafar, L., Beg, M. and Siddiqui, O.A. (2021) Association of Mean Platelet Volume with Risk Factors and Functional Outcome in Acute Ischemic Stroke. Journal of Neurosciences in Rural Practice, 12, 764-769. https://doi.org/10.1055/s-0041-1735326
|
[19]
|
Karpatkin, S. (1969) Heterogeneity of Human Platelets. I. Metabolic and Kinetic Evidence Suggestive of Young and Old Platelets. Journal of Clinical Investigation, 48, 1073-1082. https://doi.org/10.1172/JCI106063
|
[20]
|
Angkananard, T., Inthanoo, T., Sricholwattana, S., Rattanajaruskul, N., Wongsoasu, A. and Roongsangmanoon, W. (2021) The Predictive role of Neutrophil-to-Lymphocyte Ratio (NLR) and Mean Platelet Volume-to-Lymphocyte Ratio (MPVLR) for Cardiovascular Events in Adult Patients with Acute Heart Failure. Mediators of Inflammation, 2021, Article ID: 6889733. https://doi.org/10.1155/2021/6889733
|
[21]
|
Hartmut, K., Gabriele, P. and Sentot, S. (2005) Functional Heterogeneity of Alloantibodies against the Human Platelet antigen (HPA)-1a. Thrombosis and Haemostasis, 94, 1224-1229. https://doi.org/10.1160/TH05-03-0159
|
[22]
|
Yan, W., Li, R.J., Jia, Q., Mu, Y., Liu, C.L. and He, K.L. (2017) Neutrophil-to-Lymphocyte Ratio Compared to N-Terminal Pro-Brain Natriuretic Peptide as a Prognostic Marker of Adverse Events in Elderly Patients with Chronic Heart Failure. Journal of Geriatric Cardiology, 14, 127-134.
|
[23]
|
Wu, F., Wang, Q., Qiao, Y., Yu, Q. and Wang, F. (2022) A new Marker of Short-Term Mortality and Poor Outcome in Patients with Acute Ischemic Stroke: Mean Platelet Volume-to-Lymphocyte Ratio. Medicine, 101, e30911. https://doi.org/10.1097/MD.0000000000030911
|
[24]
|
黄剑桥, 谢兴宇. 胱抑素C与心力衰竭相关性的研究进展[J]. 临床内科杂志, 2022, 39(2): 142-144.
|
[25]
|
Correa, S., Morrow, D.A., Braunwald, E., Davies, R.Y., Goodrich, E.L., Murphy, S.A., Cannon, C.P. and O’Donoghue, M.L. (2018) Cystatin C for Risk Stratification in Patients after an Acute Coronary Syndrome. Journal of the American Heart Association, 7, e009077. https://doi.org/10.1161/JAHA.118.009077
|
[26]
|
Zheng, T., Tang, A.M., Huang, Y.L. and Chen, J. (2022) Non-Linear Association of Cystatin C and All-Cause Mortality of Heart Failure: A Secondary Analysis Based on a Published Database. Frontiers in Cardiovascular Medicine, 9, Article 930498. https://doi.org/10.3389/fcvm.2022.930498
|
[27]
|
黄志平, 崔巍, 乔雪峰, 等. 慢性心力衰竭患者血清胱抑素C水平变化的meta分析[J]. 临床心血管病杂志, 2018, 34(9): 909-913. https://doi.org/10.13201/j.issn.1001-1439.2018.09.016
|
[28]
|
王传合, 李志超, 佟菲, 等. 血清胱抑素C联合N末端B型利钠肽原对心力衰竭患者院内死亡的评估价值[J]. 中国循环杂志, 2020, 35(10): 990-995.
|
[29]
|
盛松, 马杭琨, 高洪阳, 等. 血清胱抑素C与心力衰竭患者死亡的关联关系: 一项1967例患者的回顾性队列研究[J]. 中国心血管杂志, 2022, 27(5): 445-449.
|
[30]
|
Durak-Nalbantic, A., Begic, E., Begic, A., Dzubur, A., Lepara, O., Baljic, R., Hamzic-Mehmedbasic, A., Rebic, D., Hodzic, E., Halimic, M. and Badnjevic, A. (2023) Biomarkers and Their Combination in a Prediction of Decompensation after an Index Hospitalization for Acute Heart Failure. Journal of Family Medicine and Primary Care, 12, 1158-1164. https://doi.org/10.4103/jfmpc.jfmpc_1456_22
|